Hypertension, left ventricular hypertrophy, and sudden death

Area of Science:

• Cardiology
• Hypertension Research
• Sudden Cardiac Death

Background:

• Left ventricular hypertrophy (LVH) is a key indicator of end-organ damage in hypertension.
• LVH is significantly associated with an increased incidence of sudden cardiac death (SCD).

Purpose of the Study:

• To review the potential mechanisms linking LVH to SCD.
• To explore the role of thrombotic/ischemic and arrhythmic factors in SCD among hypertensive patients with LVH.
• To examine the impact of LVH regression on patient prognosis.

Main Methods:

• Literature review of studies investigating the relationship between LVH and SCD.
• Analysis of mechanisms including endothelial dysfunction, hypercoagulable state, and electrophysiologic abnormalities.
• Evaluation of research on LVH regression and its prognostic implications.

Main Results:

• SCD in LVH may stem from thrombotic/ischemic events or arrhythmias.
• Myocardial ischemia, even without significant coronary artery disease, is a potential factor.
• Abnormalities in flow-mediated dilatation, endothelial function, and hypercoagulability are observed in hypertension with LVH.
• Electrophysiologic abnormalities predispose LVH patients to arrhythmias.

Conclusions:

• LVH presents multiple potential pathways contributing to SCD in hypertensive individuals.
• Further research is needed to define the exact role of vascular and hemostatic abnormalities in SCD pathogenesis.
• Investigating LVH regression is crucial for understanding potential prognostic benefits and improving outcomes.